Regencell Bioscience Holdings (RGC) Prepaid Assets (2021 - 2025)
Regencell Bioscience Holdings (RGC) reported Prepaid Assets of $5798.0 for Q2 2025, down 96.2% on a YoY basis from $152778.0 in Q2 2024, and down 96.2% quarter-over-quarter from $152778.0 in Q2 2024.
Regencell Bioscience Holdings (RGC) Prepaid Assets (2021 - 2025) Analysis & Trends
Regencell Bioscience Holdings has reported Prepaid Assets for 5 years, with the latest figure at $5798.0 in Q2 2025.
- For the quarter ending Q2 2025, Prepaid Assets fell 96.2% year-over-year to $5798.0; the trailing twelve-month figure through Jun 2025 stood at $5798.0 (down 96.2% YoY), and the FY2025 full-year result was $5798.0, down 96.2% from the prior year.
- Prepaid Assets for Q2 2025 stood at $5798.0, down from $152778.0 in the prior quarter.
- The five-year high for Prepaid Assets was $152778.0 in Q2 2024, with the low at $5798.0 in Q2 2025.
- Historically, Prepaid Assets has averaged $50031.6 across 5 years, with a median of $27598.0 in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 271.14% — and 2025, when it plunged 96.2%.
- Regencell Bioscience Holdings' Prepaid Assets stood at $7436.0 in 2021, then jumped by 271.14% to $27598.0 in 2022, then soared by 104.9% to $56548.0 in 2023, then jumped by 170.17% to $152778.0 in 2024, then sank by 96.2% to $5798.0 in 2025.
- The last three Prepaid Assets figures came in at $5798.0 (Q2 2025), $152778.0 (Q2 2024), and $56548.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Regencell Bioscience Holdings | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 5,798.00 |
| Jun 30, 2024 | 152,778.00 |
| Jun 30, 2023 | 56,548.00 |
| Jun 30, 2022 | 27,598.00 |
| Jun 30, 2021 | 7,436.00 |